PJP
PJP
About Invesco Pharmaceuticals ETF
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum,...
About Invesco Pharmaceuticals ETF
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum,...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 PFE | Pfizer Inc. | 5.30% | 785.36K | $21.38M |
 JNJ | Johnson & Johnson | 5.03% | 86.55K | $20.30M |
 GILD | Gilead Sciences, Inc. | 4.95% | 144.37K | $20.00M |
 MRK | Merck & Co., Inc. | 4.92% | 171.99K | $19.86M |
 ABBV | AbbVie Inc. | 4.87% | 93.31K | $19.50M |
 AMGN | Amgen Inc. | 4.82% | 55.67K | $19.45M |
 LLY | Eli Lilly and Company | 4.58% | 20.45K | $18.49M |
 ABT | Abbott Laboratories | 4.43% | 186.03K | $17.76M |
 TVTX | Travere Therapeutics, Inc. | 3.74% | 382.29K | $15.12M |
 LQDA | Liquidia Corporation | 3.61% | 351.66K | $14.56M |
 UTHR | United Therapeutics Corporation | 3.59% | 24.93K | $14.48M |
 CORT | Corcept Therapeutics Incorporated | 3.52% | 323.60K | $14.23M |
 LGND | Ligand Pharmaceuticals Incorporated | 3.45% | 62.46K | $13.94M |
 JAZZ | Jazz Pharmaceuticals plc | 3.33% | 67.91K | $13.43M |
 HRMY | Harmony Biosciences Holdings, Inc. | 3.05% | 418.77K | $12.32M |
 ANIP | ANI Pharmaceuticals, Inc. | 2.98% | 153.91K | $12.02M |
 INVA | Innoviva, Inc. | 2.95% | 504.06K | $11.90M |
 OCUL | Ocular Therapeutix, Inc. | 2.89% | 1.32M | $11.68M |
 BMY | Bristol-Myers Squibb Company | 2.83% | 191.64K | $11.30M |
 REGN | Regeneron Pharmaceuticals, Inc. | 2.82% | 15.29K | $11.40M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
IrelandSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States IrelandHoldings (Top 20)
PFE
Pfizer Inc.
JNJ
Johnson & Johnson
GILD
Gilead Sciences, Inc.
MRK
Merck & Co., Inc.
ABBV
AbbVie Inc.
AMGN
Amgen Inc.
LLY
Eli Lilly and Company
ABT
Abbott Laboratories
TVTX
Travere Therapeutics, Inc.
LQDA
Liquidia Corporation
UTHR
United Therapeutics Corporation
CORT
Corcept Therapeutics Incorporated
LGND
Ligand Pharmaceuticals Incorporated
JAZZ
Jazz Pharmaceuticals plc
HRMY
Harmony Biosciences Holdings, Inc.
ANIP
ANI Pharmaceuticals, Inc.
INVA
Innoviva, Inc.
OCUL
Ocular Therapeutix, Inc.
BMY
Bristol-Myers Squibb Company
REGN
Regeneron Pharmaceuticals, Inc.